Prevention of Alzheimer's Disease: Current Considerations
Select Videos & Slides
8th Leonard Berg Symposium
September 28, 2012
Eric P. Newman Education Center at Washington University
Welcome & Opening Remarks - Video
Setting the Stage for Secondary Prevention Trials in Alzheimer's Disease - Video // Slides
John C. Morris, MD, Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology, Professor of Pathology and Immunology, Professor of Physical Therapy, and Professor of Occupational Therapy at Washington University School of Medicine, Director, Knight Alzheimer's Disease Research Center, Washington University School of Medicine
Trans-synaptic Propagation of Tauopathy - Anatomic Considerations, Mechanistic Insight and Therapeutic Possibilities - Video // Slides
Karen Duff, PhD, Professor, Department of Pathology and Cell Biology Columbia University Medical Center, and Department of Integrative Neuroscience, New York State Psychiatric Institute
Adapting Proteostasis to Ameliorate Aggregation-Associated Degenerative Diseases - Video // Slides
Jeffery W. Kelly, PhD, Lita Annenberg Hazen Professor of Chemistry, Chairman, Department of Molecular and Experimental Medicine, The Scripps Research Institute
Development of Statins for Treatment of Hypercholesterolemia - Video // Slides
Scott Grundy, MD, PhD, Professor, Distinguished Chair in Human Nutrition, UT Southwestern Medical Center
*This video has been shortened by six minutes due to camera malfunction
Question and Answer Panel #1 - Video
The ‘A4’ Trial: Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease - Video // Slides
Reisa A. Sperling, MD, Director, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Aging Brain Study, Massachusetts General Hospital, Associate Professor of Neurology, Harvard Medical School
Dominantly Inherited Alzheimer Network Trials: An Opportunity to Prevent Dementia - Video // Slides
Randall J. Bateman, MD, Charles F. and Joanne Knight Distinguished Professor of Neurology, Washington University in St. Louis
Effect of FAD Mutations on the Enzymatic Activity of Gamma-Secretase - Video // Slides
Bart De Strooper, MD, PhD, VIB Center for the Biology of Disease, VIB Center for Human Genetics, KU Leuven
Challenges in Selecting Biomarker Outcomes in AD Clinical Trials - Video // Slides
Stephen Salloway, MD, MS, Professor of Neurology and Psychiatry, The Warren Alpert Medical School, Brown University, Director of Neurology and the Memory and Aging Program, Butler Hospital
Four Generations of Early Onset Alzheimer’s Disease - Video
Rachel C. Huber, DIAN Participant
Four Generations of Early Onset Alzheimer’s Disease - Video
Joe Heinrichs, DIAN Participant
